Annual report [Section 13 and 15(d), not S-K Item 405]

Fair Value of Financial Instruments - Summary of Contingent Consideration Related to Acquisition (Details)

v3.26.1
Fair Value of Financial Instruments - Summary of Contingent Consideration Related to Acquisition (Details) - USD ($)
12 Months Ended
Feb. 21, 2025
Dec. 31, 2025
Dec. 31, 2024
Business Combination [Line Items]      
Balance, beginning   $ 0  
Change in fair value contingent consideration $ (4,435,443) (1,373,942) $ 0
Balance, ending   3,061,501 0
CorHepta [Member]      
Business Combination [Line Items]      
Balance, beginning   0 0
Additions   4,435,443 0
Payments   0 0
Change in fair value contingent consideration   (1,373,942) 0
Balance, ending   $ 3,061,501 $ 0